Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
The Canadian Journal of Cardiology
|
September 2, 2019
The Use of Renin-Angiotensin System Inhibitors in Patients With Chronic Kidney Disease
Silvia J Leon, Navdeep Tangri
Current Opinion in Nephrology and Hypertension
|
December 26, 2021
Can chronic kidney disease lead to chronic heart failure, and does worsening chronic heart failure lead to chronic kidney disease progression
Silvia J Leon, Navdeep Tangri
Kidney International
|
October 26, 2019
The impact of epilepsy and its treatment in patients with end-stage renal disease
Silvia J Leon, Navdeep Tangri
Kidney360
|
September 30, 2022
Balancing Hyperkalemia Risks with Clinical Benefits of Renin-Angiotensin-Aldosterone Inhibitors/Mineralocorticoid Receptor Antagonists Blockade: It's Apples and Oranges
Silvia J Leon, Navdeep Tangri
Jornal Brasileiro De Nefrologia
|
August 12, 2020
Metabolic acidosis in patients with kidney disease
Silvia J Leon, Navdeep Tangri
Current Opinion in Nephrology and Hypertension
|
February 22, 2023
Adverse effects during treatment with renin-angiotensin-aldosterone system inhibitors; should we stay or should we stop?
Silvia J Leon, Juan Jesus Carrero
Current Opinion in Nephrology and Hypertension
|
March 14, 2019
New therapies for hyperkalemia
Silvia J Leon, Oksana Harasemiw, Navdeep Tangri
The American Journal of Cardiology
|
May 17, 2023
Ticagrelor as Compared to Clopidogrel Following Percutaneous Coronary Intervention for Acute Coronary Syndrome
Evan J Wiens, Silvia J Leon, Reid Whitlock, et al.
Kidney International Reports
|
May 20, 2021
Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort
Ingrid Hougen, Silvia J Leon, Reid Whitlock, et al.
Clinical Kidney Journal
|
August 25, 2022
Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors
Hongru Ren, Silvia J Leon, Reid Whitlock, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
The Canadian Journal of Cardiology
|
September 2, 2019
The Use of Renin-Angiotensin System Inhibitors in Patients With Chronic Kidney Disease
Silvia J Leon, Navdeep Tangri
Current Opinion in Nephrology and Hypertension
|
December 26, 2021
Can chronic kidney disease lead to chronic heart failure, and does worsening chronic heart failure lead to chronic kidney disease progression
Silvia J Leon, Navdeep Tangri
Kidney International
|
October 26, 2019
The impact of epilepsy and its treatment in patients with end-stage renal disease
Silvia J Leon, Navdeep Tangri
Kidney360
|
September 30, 2022
Balancing Hyperkalemia Risks with Clinical Benefits of Renin-Angiotensin-Aldosterone Inhibitors/Mineralocorticoid Receptor Antagonists Blockade: It's Apples and Oranges
Silvia J Leon, Navdeep Tangri
Jornal Brasileiro De Nefrologia
|
August 12, 2020
Metabolic acidosis in patients with kidney disease
Silvia J Leon, Navdeep Tangri
Current Opinion in Nephrology and Hypertension
|
February 22, 2023
Adverse effects during treatment with renin-angiotensin-aldosterone system inhibitors; should we stay or should we stop?
Silvia J Leon, Juan Jesus Carrero
Current Opinion in Nephrology and Hypertension
|
March 14, 2019
New therapies for hyperkalemia
Silvia J Leon, Oksana Harasemiw, Navdeep Tangri
The American Journal of Cardiology
|
May 17, 2023
Ticagrelor as Compared to Clopidogrel Following Percutaneous Coronary Intervention for Acute Coronary Syndrome
Evan J Wiens, Silvia J Leon, Reid Whitlock, et al.
Kidney International Reports
|
May 20, 2021
Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort
Ingrid Hougen, Silvia J Leon, Reid Whitlock, et al.
Clinical Kidney Journal
|
August 25, 2022
Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors
Hongru Ren, Silvia J Leon, Reid Whitlock, et al.
Page
of 3